Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ana Carolina Ferreira Cardoso"'
Autor:
Marcia Torresan Delamain, Ana Carolina Ferreira Cardoso, Fernando Vieira Pericole, Sérgio Shusterschitz da Silva Araújo, Laura Fogliatto, Marcia Higashi, Juliana Pereira, Roberto Luiz da Silva, Gustavo Werutsky, Patrícia de Paulo Giacon Radtke, Marco Aurélio Salvino, Vivienne Castilho
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 585-598 (2024)
Abstract Introduction RTXM83, a biosimilar of rituximab, was approved after physicochemical, functional, non-clinical, and clinical studies demonstrated their similarity; these studies included RTXM83-AC-01-11, a multicentric double-blind internation
Externí odkaz:
https://doaj.org/article/8d68eaeacb15499abfd7b18e99202271
Publikováno v:
Women's Health Reports, Vol 5, Iss 1, Pp 460-472 (2024)
Background: In Brazil, where approximately 48.7 million women are of reproductive age, understanding contraceptive practices is essential for addressing public health challenges. This study evaluated into the knowledge, usage, and perceptions of cont
Externí odkaz:
https://doaj.org/article/8f6811fe17ea4dcea4c11573a2d224aa
Autor:
Ana Carolina Ferreira Cardoso, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos, Roger eChammas
Publikováno v:
Frontiers in Oncology, Vol 6 (2016)
Galectin-3 is a member of the b-galactoside binding lectin family, whose expression is often dysregulated in cancers. While galectin-3 is usually an intracellular protein, found in the nucleus and in the cytoplasm; under certain conditions, galectin-
Externí odkaz:
https://doaj.org/article/bab48b3ae8054ac2944b9ddb1b9ec089
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
A patogênese e o estadiamento do melanoma são clinicamente bem caracterizados, entretanto, muitas variações são observadas no que diz respeito à progressão e respostas terapêuticas. Mecanismos intrínsecos das células de melanoma contribuem
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
A heterogeneidade intratumoral é um fenômeno extremamente importante para entender a progressão tumoral e a resposta à intervenção terapêutica. A galectina-3 pertence à família das lectinas, possuem a função de reconhecimento e ligação
Autor:
Jessika Bridi, Ana Carolina Ferreira Cardoso, Paula Bonilha Fernandes, Maura Gonzaga Lapa, Sergio Schusterschitz, Joao Samuel Farias, Marco Aurelio Salvino, Marcia Higashi, Patricia Giacon, Juliana Pereira, Marcia Delamain, Vivienne Castilho
Publikováno v:
Blood. 140:13236-13238
Autor:
Ana Carolina Ferreira Cardoso, Debora De Melo Gagliato, Natália Mesquita Brito, Maura Gonzaga Lapa, Érida Aparecida Pinto Magaton, Renata Virgínia Cavalcanti Santos, Vivienne Carduz Castilho
Publikováno v:
Journal of Clinical Oncology. 40:e12524-e12524
e12524 Background: The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) defines a biosimilar as a biological molecule product that is highly similar to and has no clinically meaningful differences from an existing approved
Autor:
Franklin Fernandes Pimentel, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, João Gonçalves, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho, Roger Chammas, Juliano Simões de Toledo
Publikováno v:
Mastology.
Objectives: Trastuzumab and pertuzumab bind to HER2 synergistically at different subdomains, improving the clinical benefit of breast cancer treatment. Recently, trastuzumab biosimilars were approved after comparison with the originator, proving high
Autor:
David R. Fogelman, Minjeong Park, Claudia Alvarez Florez Bedoya, Huamin Wang, Maria Q.B. Petzel, Michael P. Kim, Matthew H.G. Katz, An Ngo-Huang, Keri Schadler, Nathan H. Parker, Ana Carolina Ferreira Cardoso, Salvador Gabriel Romero
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
The efficacy of chemotherapy is reduced by dysfunctional tumor vasculature, which may limit chemotherapy delivery to tumors. Preclinical studies have shown that moderate aerobic exercise improves tumor vascular function and increases chemotherapy eff